Loading…
Cosmos Health Inc.
How the company evolved, year by year. Revenue and debt come from the annual reports — for most companies, the 10-K filings with the SEC since 2009; dividends from the payments themselves.
The bars are a balance on the closing date; the lines are what happened during the year. Revenue above equity is ordinary, not an anomaly — it means the company turns its capital over more than once a year.
Major managers that reported this stock in their latest 13F.
None of the investors we track reported a position in COSM.
▼ -91.4% over 5Y.
today you would have $75.61▼ -92.4%
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
The last 4 closed years. Each multiple uses that year’s closing price and that year’s reported numbers — not today’s. The range is set by the annual reports on record.
| Indicator | Median | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Year-end price | $0.50 | $0.67 | $1.41 | $4.56 | |
| P/S | 0.4x | 0.3x | 0.3x | 0.4x | 1.0x |
| P/B | 0.9x | 1.1x | 0.6x | 0.6x | 1.2x |
| EPS | -$0.63 | -$1.17 | -$2.15 | -$33.16 | |
| Profit margin | -29.53% | -29.33% |
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| ONMDOneMedNet Corp | $0.63 | — | — | — | — | $37.53M |
| HBIOHarvard Bioscience Inc | $7.92 | — | 4.9x | — | -89.95% | $36.05M |
| BDMDBaird Medical Investment Holdings Ltd | $1.12 | — | 0.7x | — | -77.60% | $35.82M |
| CPHIChina Pharma Holdings Inc | $0.90 |
Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, the United Arab Emirates, Albania, North Macedonia, and Cyprus. The company provides prescription medications, over-the-counter drugs, medical devices, food supplements, nutraceuticals, cosmetics and other healthcare products under the Sky Premium Life and Mediterranation brand names. It offers ASTO-CHOL (Pravastatin), Diorium (Omeprazole), HEART-FREE (Clopidogrel), LIPICHOL (Atorvastatin), Miltus (Donepezil), Newzypra (Olanzapine), PNEUMO-KAST (Montelukast), Sahar (Pioglitazone), VIVALCID (Leucovorin), and Diabit-is (Sitagliptin). In addition, the company offers branded biocides and antiseptic soaps under the C-Sept and C-Scrub brand names; and other pharmaceutical products include Melatonin Spray, used to reduce insomnia and jet lag; Otikon ear drops, which is a Class II medical device in the form of ear drops; and baby foods, such as organic powder milk, pasta with minced meat, whole grain rice cereals, whole grain cereal porridges, and organic rice creams with vanilla milk, as well as pear, carrot and banana purée under the Bio-bebe brand. It serves wholesalers and retail healthcare providers. The company was founded in 2009 and is headquartered in Thessaloniki, Greece.
Company description provided by Yahoo Finance.
| -29.73% |
| -34.74% |
| -27.47% |
| ROE | -58.71% | -103.91% | -65.96% | -51.45% | -34.88% |
Median, not average: a single year of near-zero profit produces a P/E of 400 and would drag an average on its own. P/E years above 200x are left out, the same cut the fair price uses — so this median matches the “its own history” method below. Price and EPS have no median: they are series that grow.
| — |
| 1.0x |
| — |
| -20.99% |
| $38.9M |
| ELUTElutia Inc | $0.88 | — | 2.5x | — | — | $38.97M |
| CRVOCervoMed Inc. | $2.60 | — | 1.5x | — | -107.62% | $39.31M |